A Computational Approach for Designing Synthetic Riboswitches for Next-Generation RNA Therapeutics

Sumit Mukherjee, Sunanda Biswas Mukherjee, Danny Barash

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Riboswitches are naturally occurring regulatory segments of RNA molecules that modulate gene expression in response to specific ligand binding. They serve as a molecular ‘switch’ that controls the RNA’s structure and function, typically influencing the synthesis of proteins. Riboswitches are unique because they directly interact with metabolites without the need for proteins, making them attractive tools in synthetic biology and RNA-based therapeutics. In synthetic biology, riboswitches are harnessed to create biosensors and genetic circuits. Their ability to respond to specific molecular signals allows for the design of precise control mechanisms in genetic engineering. This specificity is particularly useful in therapeutic applications, where riboswitches can be synthetically designed to respond to disease-specific metabolites, thereby enabling targeted drug delivery or gene therapy. Advancements in designing synthetic riboswitches for RNA-based therapeutics hinge on sophisticated computational techniques, which are described in this chapter. The chapter concludes by underscoring the potential of computational strategies in revolutionizing the design and application of synthetic riboswitches, paving the way for advanced RNA-based therapeutic solutions.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages193-204
Number of pages12
DOIs
StatePublished - 1 Jan 2025

Publication series

NameMethods in Molecular Biology
Volume2847
ISSN (Print)1064-3745
ISSN (Electronic)1940-6029

Keywords

  • Inverse RNA Folding
  • RNA-based therapeutics
  • Riboswitch
  • Ribozyme
  • Synthetic biology

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Fingerprint

Dive into the research topics of 'A Computational Approach for Designing Synthetic Riboswitches for Next-Generation RNA Therapeutics'. Together they form a unique fingerprint.

Cite this